Home » Market News » DirectorsTalk Highlights » How diagnostic test performance is measured
Avacta Group Plc

How diagnostic test performance is measured

In this video, Avacta’s Chief Executive Officer Alastair Smith explains how diagnostic test performance is measured.

Avacta Group Plc (LON:AVCT) offers reagents and therapeutics based on Affimer technology for diagnostic and research applications in the United Kingdom. The company’s custom Affimer products are also used in drugs and biomarkers discovery in biotech research and development.

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.